Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population
about
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityNSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesNew insights into the use of currently available non-steroidal anti-inflammatory drugsNonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskProton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control studySafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksPrescription and comorbidity screening following consultation for acute gout in primary care.Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data.Rationally designed multitarget agents against inflammation and pain.Recent advances in peptic ulcer bleeding.Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)Etoricoxib and the treatment of ankylosing spondylitis.Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidancePrescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea.Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical recordsRisk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug.IL-10-producing regulatory B cells (B10 cells) in autoimmune disease.Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertensionAnalyzing partially missing confounder information in comparative effectiveness and safety research of therapeuticsSociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort studyComorbidities affect risk of nonvariceal upper gastrointestinal bleeding.Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor.Myths and facts in the use of anti-inflammatory drugs.Perforated peptic ulcer - an update.Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.Gastrointestinal prophylaxis in neurocritical care.Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigationManaging the adverse effects of nonsteroidal anti-inflammatory drugs.Room for improvement: unmet needs in postoperative pain management.Therapeutic management of recurrent peptic ulcer disease.Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.Defining a reference set to support methodological research in drug safety.Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.
P2860
Q24615651-6C5F1B3E-49EB-438B-9CBC-6CC4423AEDAEQ26784322-CC036CA1-1EED-40C1-9FA7-EA7E610732E9Q26852330-1C5444DB-CD95-4EF8-8689-2B4C97851794Q26864640-F723A53C-8C47-4DC0-957B-36F8F4476880Q28211313-CB620E4D-98A1-4686-BFE1-B29F39DFB8C4Q30629677-1C6787F6-9FE6-4DAF-8005-13B64349CF64Q30888155-9B3A47E7-BB33-4A50-A3EA-05CAF1A3B387Q33304363-8A624553-8A98-4CC9-BD89-BDE6327214B0Q33960685-75DF1320-D08E-4518-977C-7AEFC50D17F5Q34076408-DD03598E-3951-49C4-B84D-7C073A250E13Q34134282-B38DEB3F-F70A-4EE3-AB97-D947E2665198Q34310573-1746518B-71B2-4B6A-873F-53AA96472064Q34466689-5B0F7F9F-CB8A-44C9-B068-487840C0A0ABQ34655792-D556FF1B-B2B9-4CAA-BB30-0FA5DADFA9D8Q34753461-276F7272-0FE1-4B4E-8DC2-7FD2C4B01656Q35117393-6F39967C-9BCB-47A2-813F-C5F7463439FEQ35138248-988F2BC5-4AEA-4E39-AA1E-616A33158A84Q35158795-9607F602-3030-4DD5-B451-D8A67F4654E5Q35569771-04379C12-C640-4412-A048-5D8203BEFFB4Q36117689-30B77CCE-FEBE-4335-9433-B8280483F67BQ36280849-EFC4EEDD-D8B3-42DB-90DB-2504B8BD71DEQ36760499-6B56E6C4-C2D7-410D-AA6A-EEB7A4925FCDQ36977040-B8E25617-D9D4-475D-A087-769BCDA013DFQ37056117-1B9D8A20-943A-41F9-ABF8-7D5F007939F0Q37160346-4F8B66FE-9785-4806-B90F-ED24C50C4477Q37182009-0F5A9690-48AC-482F-AA26-5389D37F871BQ37256004-22A3BAF3-EFFF-4578-8D09-D45F2DF5080EQ37402473-674B6F55-40F1-4ED5-9E54-17F63481E46BQ37476911-B661640E-A492-40A9-B476-F2DA3D959D5AQ37587472-53452FE6-2713-4F68-903B-21A65BB06E2AQ37731873-FA6DBE42-358C-422D-AAB2-7C8238860318Q37862577-70CE65A0-C679-470C-8990-D281B5E3F955Q37900222-A938A643-E9AB-4E6A-8CA3-293D28712C42Q37944018-5D9F6C8B-A41A-45E9-82B5-F5A7E76293E3Q37960540-246BEE2A-FFE5-4288-B26A-06D3E237E202Q38006982-585F98F3-72B8-4801-BF7D-E8FB40CF12DDQ38032319-97861286-F181-49AC-9AED-B26C3A64EA3DQ38041462-023D5B16-C7D4-4777-A66A-3ABBC3504EB5Q38156066-870402D6-8B40-4BB5-9612-1956AA9E8DA4Q38471578-29AF600C-8C6C-439E-9E1B-6646A676273B
P2860
Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Risk of upper gastrointestinal ...... XIBs in the general population
@ast
Risk of upper gastrointestinal ...... XIBs in the general population
@en
Risk of upper gastrointestinal ...... XIBs in the general population
@nl
type
label
Risk of upper gastrointestinal ...... XIBs in the general population
@ast
Risk of upper gastrointestinal ...... XIBs in the general population
@en
Risk of upper gastrointestinal ...... XIBs in the general population
@nl
prefLabel
Risk of upper gastrointestinal ...... XIBs in the general population
@ast
Risk of upper gastrointestinal ...... XIBs in the general population
@en
Risk of upper gastrointestinal ...... XIBs in the general population
@nl
P3181
P1433
P1476
Risk of upper gastrointestinal ...... XIBs in the general population
@en
P2093
Laura Barreales Tolosa
Luis A García Rodríguez
P304
P3181
P356
10.1053/J.GASTRO.2006.12.007
P407
P577
2007-02-01T00:00:00Z